During the past decade, Shijiazhuang Yiling Pharmaceutical Co.,Ltd conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shijiazhuang Yiling Pharmaceutical Co.,Ltd" are "Pain" (3 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Shijiazhuang Yiling Pharmaceutical Co.,Ltd" in a lesser frequency.

Most popular intervention types in "Shijiazhuang Yiling Pharmaceutical Co.,Ltd" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Felbinac Trometamol Injection" (3 trials), "Placebos" (3 trials), "Finamine tablets" (1 trials) and "Placebo tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shijiazhuang Yiling Pharmaceutical Co.,Ltd" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Shijiazhuang Yiling Pharmaceutical Co.,Ltd". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 2 completed trials in Shijiazhuang Yiling Pharmaceutical Co.,Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shijiazhuang Yiling Pharmaceutical Co.,Ltd, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".